IRIS Accounts Production v24.3.0.553 04165383 Board of Directors Board of Directors 1.4.23 31.3.24 31.3.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh041653832023-03-31041653832024-03-31041653832023-04-012024-03-31041653832022-05-31041653832022-06-012023-03-31041653832023-03-3104165383ns15:EnglandWales2023-04-012024-03-3104165383ns14:PoundSterling2023-04-012024-03-3104165383ns10:Director12023-04-012024-03-3104165383ns10:Director22023-04-012024-03-3104165383ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3104165383ns10:SmallEntities2023-04-012024-03-3104165383ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3104165383ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3104165383ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3104165383ns10:FullAccounts2023-04-012024-03-310416538312023-04-012024-03-3104165383ns10:RegisteredOffice2023-04-012024-03-3104165383ns5:CurrentFinancialInstruments2024-03-3104165383ns5:CurrentFinancialInstruments2023-03-3104165383ns5:ShareCapital2024-03-3104165383ns5:ShareCapital2023-03-3104165383ns5:RetainedEarningsAccumulatedLosses2024-03-3104165383ns5:RetainedEarningsAccumulatedLosses2023-03-3104165383ns5:NetGoodwill2023-04-012024-03-3104165383ns5:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3104165383ns5:NetGoodwill2023-03-3104165383ns5:NetGoodwill2024-03-3104165383ns5:NetGoodwill2023-03-3104165383ns5:LeaseholdImprovements2023-03-3104165383ns5:FurnitureFittings2023-03-3104165383ns5:MotorVehicles2023-03-3104165383ns5:ComputerEquipment2023-03-3104165383ns5:LeaseholdImprovements2023-04-012024-03-3104165383ns5:FurnitureFittings2023-04-012024-03-3104165383ns5:MotorVehicles2023-04-012024-03-3104165383ns5:ComputerEquipment2023-04-012024-03-3104165383ns5:LeaseholdImprovements2024-03-3104165383ns5:FurnitureFittings2024-03-3104165383ns5:MotorVehicles2024-03-3104165383ns5:ComputerEquipment2024-03-3104165383ns5:LeaseholdImprovements2023-03-3104165383ns5:FurnitureFittings2023-03-3104165383ns5:MotorVehicles2023-03-3104165383ns5:ComputerEquipment2023-03-3104165383ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-3104165383ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-31
REGISTERED NUMBER: 04165383 (England and Wales)










Financial Statements

for the Year Ended 31 March 2024

for

Heath Pharmacy Limited

Heath Pharmacy Limited (Registered number: 04165383)

Contents of the Financial Statements
for the Year Ended 31 March 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Heath Pharmacy Limited

Company Information
for the Year Ended 31 March 2024







DIRECTORS: H Patel
P Takkallapally





REGISTERED OFFICE: 57 New Walk
Leicester
LE1 7EA





REGISTERED NUMBER: 04165383 (England and Wales)






Heath Pharmacy Limited (Registered number: 04165383)

Balance Sheet
31 March 2024

31.3.24 31.3.23
Notes £    £    £    £   
Fixed assets
Intangible assets 4 - -
Tangible assets 5 16,923 18,283
16,923 18,283

Current assets
Stocks 57,068 41,514
Debtors: amounts falling due within one year 6 20,734 33,028
Cash at bank and in hand 185,818 140,604
263,620 215,146
Creditors
Amounts falling due within one year 7 208,932 221,828
Net current assets/(liabilities) 54,688 (6,682 )
Total assets less current liabilities 71,611 11,601

Provisions for liabilities 1,994 1,875
Net assets 69,617 9,726

Capital and reserves
Called up share capital 1,000 1,000
Retained earnings 68,617 8,726
69,617 9,726

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Heath Pharmacy Limited (Registered number: 04165383)

Balance Sheet - continued
31 March 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 27 June 2024 and were signed on its behalf by:




H Patel - Director



P Takkallapally - Director


Heath Pharmacy Limited (Registered number: 04165383)

Notes to the Financial Statements
for the Year Ended 31 March 2024


1. Statutory information

Heath Pharmacy Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. Accounting policies

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 0, is being amortised evenly over its estimated useful life of nil years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Heath Pharmacy Limited (Registered number: 04165383)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024


2. Accounting policies - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. Employees and directors

The average number of employees during the year was 9 (2023 - 10 ) .

4. Intangible fixed assets
Goodwill
£   
Cost
At 1 April 2023
and 31 March 2024 300,000
Amortisation
At 1 April 2023
and 31 March 2024 300,000
Net book value
At 31 March 2024 -
At 31 March 2023 -

5. Tangible fixed assets
Improvements Fixtures
to and Motor Computer
property fittings vehicles equipment Totals
£    £    £    £    £   
Cost
At 1 April 2023 39,796 35,390 1,200 15,639 92,025
Additions - - - 3,860 3,860
At 31 March 2024 39,796 35,390 1,200 19,499 95,885
Depreciation
At 1 April 2023 31,379 28,418 666 13,279 73,742
Charge for year 1,989 1,045 133 2,053 5,220
At 31 March 2024 33,368 29,463 799 15,332 78,962
Net book value
At 31 March 2024 6,428 5,927 401 4,167 16,923
At 31 March 2023 8,417 6,972 534 2,360 18,283

Heath Pharmacy Limited (Registered number: 04165383)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024


6. Debtors: amounts falling due within one year
31.3.24 31.3.23
£    £   
Trade debtors 577 9,236
Chemix Group Limited - 11,000
VAT 20,157 12,792
20,734 33,028

7. Creditors: amounts falling due within one year
31.3.24 31.3.23
£    £   
Bank loans and overdrafts - 1
Trade creditors 141,182 128,547
Tax 28,975 -
Social security and other taxes 2,639 1,623
Other creditors 14,444 11,201
David Wilkinson - 71,547
Chemix Group Limited 10,058 -
Directors' loan accounts 6,629 6,029
Accrued expenses 5,005 2,880
208,932 221,828